DOCSLIB.ORG

DNA Methylation Status of Key Cell-Cycle Regulators Such As CDKNA2/P16 and CCNA1 Correlates with Treatment Response to Doxorubic

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
DNA Methylation Status of Key Cell-Cycle Regulators Such As CDKNA2/P16 and CCNA1 Correlates with Treatment Response to Doxorubic Published OnlineFirst October 7, 2014; DOI: 10.1158/1078-0432.CCR-14-0297 Clinical Cancer Personalized Medicine and Imaging Research DNA Methylation Status of Key Cell-Cycle Regulators Such as CDKNA2/p16 and CCNA1 Correlates with Treatment Response to Doxorubicin and 5-Fluorouracil in Locally Advanced Breast Tumors Jovana Klajic1,2,3, Florence Busato4, Hege Edvardsen3, Nizar Touleimat4, Thomas Fleischer2,3, Ida Bukholm5,6, Anne-Lise Børresen-Dale2,3, Per Eystein Lønning7,8,Jorg€ Tost4, and Vessela N. Kristensen1,2,3 Abstract Purpose: To explore alterations in gene promoter methylation as a potential cause of acquired drug resistance to doxorubicin or combined treatment with 5-fluorouracil and mitomycin C in human breast cancers. Experimental Design: Paired tumor samples from locally advanced breast cancer patients treated with doxorubicin and 5-fluorouracil-mitomycin C were used in the genome-wide DNA methylation analysis as discovery cohort. An enlarged cohort from the same two prospective studies as those in the discovery cohort was used as a validation set in pyrosequencing analysis. Results: A total of 469 genes were differentially methylated after treatment with doxorubicin and revealed a significant association with canonical pathways enriched for immune cell response and cell-cycle regulating genes including CDKN2A, CCND2, CCNA1, which were also associated to treatment response. Treatment with FUMI resulted in 343 differentially methylated genes representing canonical pathways such as retinoate biosynthesis, gai signaling, and LXR/RXR activation. Despite the clearly different genes and pathways involved in the metabolism and therapeutic effect of both drugs, 46 genes were differentially methylated before and after treatment with both doxorubicin and FUMI. DNA methylation profiles in genes such as BRCA1, FOXC1, and IGFBP3, and most notably repetitive elements like ALU and LINE1, were associated with TP53 mutations status. Conclusion: We identified and validated key cell-cycle regulators differentially methylated before and after neoadjuvant chemotherapy such as CDKN2A and CCNA1 and reported that methylation patterns of these genes may be potential predictive markers to anthracycline/mitomycine sensitivity. Clin Cancer Res; 1–10. Ó2014 AACR. Introduction 1Division of Medicine, Department of Clinical Molecular Biology and Initially implemented for locally advanced breast cancers, Laboratory Science (EpiGen), Akershus University Hospital, Lørenskog, primary (presurgery) systemic therapy is nowadays increas- 2 Norway. K.G. Jebsen Center for Breast Cancer Research, Institute for ingly used for operable breast carcinomas. Multiple studies Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. 3Department of Genetics, Institute for Cancer Research, OUS Radiumhos- have correlated a pathologic complete response to primary pitalet Montebello, Oslo, Norway. 4Laboratory for Epigenetics and Envi- chemotherapy with improved prognosis (1). However, ronment, Centre National de Genotypage, CEA—Institut de Genomique, although factors like hormone receptor status, HER2 over- Evry, France. 5Department of Surgery, Akerhus University Hospital, Oslo, Norway. 6Institute for Clinical Medicine, Faculty of Medicine, University expression, and gene expression signatures do correlate with of Oslo, Norway. 7Section of Oncology, Institute of Clinical Science, pathologic complete response (2, 3), the predictive power University of Bergen, Bergen, Norway. 8Department of Oncology, Hauke- land University Hospital, Bergen, Norway. of each parameter is modest, and the cause of drug resis- tance remains poorly understood (4). TP53 mutation status Note: Supplementary data for this article are available at Clinical Cancer Research Online (http://clincancerres.aacrjournals.org/). is another strong prognostic factor, being associated with worse prognosis after treatment with anthracycline as well Corresponding Author: Vessela N. Kristensen, Faculty of Medicine, Insti- tute for Clinical Medicine, University of Oslo, 0372, Oslo, Norway. Phone: as mitomycin-containing chemotherapy (5, 6). 47-22-78-13-75/47-920-68-432; Fax: 47-22-78-13-95; E-mail: Beside genetic abnormalities, epigenetic alterations [email protected] may contribute to breast carcinogenesis and tumor doi: 10.1158/1078-0432.CCR-14-0297 growth. A large number of genes have been shown to be Ó2014 American Association for Cancer Research. inactivated in breast cancer through gene silencing by www.aacrjournals.org OF1 Downloaded from clincancerres.aacrjournals.org on September 27, 2021. © 2014 American Association for Cancer Research. Published OnlineFirst October 7, 2014; DOI: 10.1158/1078-0432.CCR-14-0297 Klajic et al. Discovery cohort (genome-wide screening) Translational Relevance Paired tumor samples from locally advanced breast can- We investigated treatment-associated changes in cer were taken before and after neoadjuvant treatment. The the DNA methylation profiles of locally advanced study comprised 19 tumors treated with doxorubicin and breast cancer patients treated with doxorubicin and 14 tumors treated with FUMI. These patients were admitted 0 5 fluorouracil-mitomycin C, prior and after neoadju- to the Haukeland University Hospital in Bergen, Norway vant chemotherapy and validates these profiles in a between 1991 and 2001 (5, 6). DNA from nine normal larger cohort. We identify and validate methylation breast tissues were collected at the Akershus University patterns of key cell-cycle regulators such as CDKN2A Hospital (Lørenskog, Norway) and included as a control and CCNA1 as potential predictive markers to anthra- of DNA methylation background to which tumor-specific cycline/mitomycine sensitivity. We report on the asso- methylation events are compared with. ciation of differentially methylated genes before and after treatment with canonical pathways enriched for Validation cohort cell-cycle regulating genes and immune cell response. An enlarged cohort comprising 85 paired tumors treated WedemonstrateanassociationbetweenTP53 muta- with doxorubicin and 39 paired tumors treated with FUMI tion status and DNA methylation levels in repetitive from the same two prospective studies as those in the elements like ALU and LINE1 and suggest that meth- discovery cohort was used as a validation set. Samples that ylation levels of these genes together with TP53 status were used for 27K arrays were also among those in valida- could be of value in predicting response to chemo- tion cohort. Clinical and molecular parameters were avail- therapy treatment. We also show an association of able for all samples. DNA from fresh-frozen tumor tissues CDKN2A to molecular subtypes and suggest that the was used in both cohorts. Study design is shown in Fig. 1. Luminal B subtype could be used in defining a group, which will benefit from chemotherapy treatment. Classification of Treatment Response The protocols enrolled patients between 1991 and 2001. Response to therapy was classified by the UICC system DNA methylation. Such findings include genes involved commonly applied at that time (11) and not the more in cell-cycle regulation (CDKN2A, CCND2), DNA repair recent RECIST system (12). Responses were classified as CR (MGMT, BRCA1, MLH1, GSTP1), regulation of cell tran- (complete response-complete disappearance of all tumor scription (HOXA5), hormone and receptor-mediated cell lesions), PR (partial response reduction 50% in the sum of signaling (ER and THRb), apoptosis, and tissue invasion all tumor lesions), PD (progressive disease-increase in the and metastasis (RASSF1A, RARb,TWIST,HIN1,CDH1; diameter of any individual tumor lesion by 25%), and ref. 7). Epigenetic silencing of these genes by DNA meth- StbD (stable disease; the condition between PR and PD). ylation is frequent and, in contrast with genetic mutation, Similar to what has been done for previous reports on these reversible (8, 9), making them potential candidates for materials (5, 6), we compared PD tumors as nonresponders pharmacologic manipulation, for example, through tar- with the combined group of tumors classified as StbD/PR as geted inhibition of DNA methyltransferases. Experimen- responders. tal studies have indicated drug-induced alterations in gene promoter methylation as a potential cause of TP53 analysis acquired drug resistance (10). Mutations in the TP53 gene were analyzed with use of The aim of this study was to explore alterations in gene genomic DNA and the temporal temperature gradient gel promoter methylation as a potential cause of acquired drug electrophoresis (TTGE) strategy (5, 6). DNA fragments resistance to doxorubicin or combined treatment with 5- covering exons 2–11 were amplified, all with a GC clamp fluorouracil (5-FU) and mitomycin C (FUMI) in human on one of the primers, and submitted to analysis by TTGE. breast cancers. To do so, we took advantage of our tissue Mutations of the TP53 gene were correlated with response to bank providing unique access to paired tumor samples chemotherapy with use of the c2 method, including Yates collected from the same patients before and after primary correction for a limited number of observations. In addi- treatment with doxorubicin or FUMI. We used the Illumina tion, the differences in the distribution of TP53 mutation Infinium 27K Human DNA Methylation BeadChip to assess among patients revealing a PD and the remaining groups to which degree the genome-wide methylation status is were analyzed with the use of Fisher exact test. associated with treatment response. Methylation
Load more

Recommended publications
  • The Cross-Talk Between Methylation and Phosphorylation in Lymphoid-Specific Helicase Drives Cancer Stem-Like Properties
    Signal Transduction and Targeted Therapy www.nature.com/sigtrans ARTICLE OPEN The cross-talk between methylation and phosphorylation in lymphoid-specific helicase drives cancer stem-like properties Na Liu1,2,3, Rui Yang1,2, Ying Shi1,2, Ling Chen1,2, Yating Liu1,2, Zuli Wang1,2, Shouping Liu1,2, Lianlian Ouyang4, Haiyan Wang1,2, Weiwei Lai1,2, Chao Mao1,2, Min Wang1,2, Yan Cheng5, Shuang Liu4, Xiang Wang6, Hu Zhou7, Ya Cao1,2, Desheng Xiao1 and Yongguang Tao1,2,6 Posttranslational modifications (PTMs) of proteins, including chromatin modifiers, play crucial roles in the dynamic alteration of various protein properties and functions including stem-cell properties. However, the roles of Lymphoid-specific helicase (LSH), a DNA methylation modifier, in modulating stem-like properties in cancer are still not clearly clarified. Therefore, exploring PTMs modulation of LSH activity will be of great significance to further understand the function and activity of LSH. Here, we demonstrate that LSH is capable to undergo PTMs, including methylation and phosphorylation. The arginine methyltransferase PRMT5 can methylate LSH at R309 residue, meanwhile, LSH could as well be phosphorylated by MAPK1 kinase at S503 residue. We further show that the accumulation of phosphorylation of LSH at S503 site exhibits downregulation of LSH methylation at R309 residue, which eventually promoting stem-like properties in lung cancer. Whereas, phosphorylation-deficient LSH S503A mutant promotes the accumulation of LSH methylation at R309 residue and attenuates stem-like properties, indicating the critical roles of LSH PTMs in modulating stem-like properties. Thus, our study highlights the importance of the crosstalk between LSH PTMs in determining its activity and function in lung cancer stem-cell maintenance.
    [Show full text]
  • Distinct Contributions of DNA Methylation and Histone Acetylation to the Genomic Occupancy of Transcription Factors
    Downloaded from genome.cshlp.org on October 8, 2021 - Published by Cold Spring Harbor Laboratory Press Research Distinct contributions of DNA methylation and histone acetylation to the genomic occupancy of transcription factors Martin Cusack,1 Hamish W. King,2 Paolo Spingardi,1 Benedikt M. Kessler,3 Robert J. Klose,2 and Skirmantas Kriaucionis1 1Ludwig Institute for Cancer Research, University of Oxford, Oxford, OX3 7DQ, United Kingdom; 2Department of Biochemistry, University of Oxford, Oxford, OX1 3QU, United Kingdom; 3Target Discovery Institute, University of Oxford, Oxford, OX3 7FZ, United Kingdom Epigenetic modifications on chromatin play important roles in regulating gene expression. Although chromatin states are often governed by multilayered structure, how individual pathways contribute to gene expression remains poorly under- stood. For example, DNA methylation is known to regulate transcription factor binding but also to recruit methyl-CpG binding proteins that affect chromatin structure through the activity of histone deacetylase complexes (HDACs). Both of these mechanisms can potentially affect gene expression, but the importance of each, and whether these activities are inte- grated to achieve appropriate gene regulation, remains largely unknown. To address this important question, we measured gene expression, chromatin accessibility, and transcription factor occupancy in wild-type or DNA methylation-deficient mouse embryonic stem cells following HDAC inhibition. We observe widespread increases in chromatin accessibility at ret- rotransposons when HDACs are inhibited, and this is magnified when cells also lack DNA methylation. A subset of these elements has elevated binding of the YY1 and GABPA transcription factors and increased expression. The pronounced ad- ditive effect of HDAC inhibition in DNA methylation–deficient cells demonstrates that DNA methylation and histone deacetylation act largely independently to suppress transcription factor binding and gene expression.
    [Show full text]
  • Small Nucleolar Rnas Determine Resistance to Doxorubicin in Human Osteosarcoma
    International Journal of Molecular Sciences Article Small Nucleolar RNAs Determine Resistance to Doxorubicin in Human Osteosarcoma Martina Godel 1, Deborah Morena 1, Preeta Ananthanarayanan 1, Ilaria Buondonno 1, Giulio Ferrero 2,3 , Claudia M. Hattinger 4, Federica Di Nicolantonio 1,5 , Massimo Serra 4 , 1 2 1, , 1, , Riccardo Taulli , Francesca Cordero , Chiara Riganti * y and Joanna Kopecka * y 1 Department of Oncology, University of Torino, 1026 Torino, Italy; [email protected] (M.G.); [email protected] (D.M.); [email protected] (P.A.); [email protected] (I.B.); [email protected] (F.D.N.); [email protected] (R.T.) 2 Department of Computer Science, University of Torino, 10149 Torino, Italy; [email protected] (G.F.); [email protected] (F.C.) 3 Department of Clinical and Biological Sciences, University of Torino, 10043 Orbassano, Italy 4 Laboratory of Experimental Oncology, Pharmacogenomics and Pharmacogenetics Research Unit, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy; [email protected] (C.M.H.); [email protected] (M.S.) 5 Candiolo Cancer Institute, FPO–IRCCS, 10060 Candiolo, Italy * Correspondence: [email protected] (C.R.); [email protected] (J.K.); Tel.: +39-0116705857 (C.R.); +39-0116705849 (J.K.) These authors equally contributed to this work. y Received: 31 May 2020; Accepted: 21 June 2020; Published: 24 June 2020 Abstract: Doxorubicin (Dox) is one of the most important first-line drugs used in osteosarcoma therapy. Multiple and not fully clarified mechanisms, however, determine resistance to Dox. With the aim of identifying new markers associated with Dox-resistance, we found a global up-regulation of small nucleolar RNAs (snoRNAs) in human Dox-resistant osteosarcoma cells.
    [Show full text]
  • Ubiquitination/Deubiquitination and Acetylation/Deacetylation
    Acta Pharmacologica Sinica (2011) 32: 139–140 npg © 2011 CPS and SIMM All rights reserved 1671-4083/11 $32.00 www.nature.com/aps Research Highlight Ubiquitination/deubiquitination and acetylation/ deacetylation: Making DNMT1 stability more coordinated Qi HONG, Zhi-ming SHAO* Acta Pharmacologica Sinica (2011) 32: 139–140; doi: 10.1038/aps.2011.3 n mammals, DNA methylation plays important role in human cancers[7, 8]. abundance of DNMT1 mutant lacking Ia crucial role in the regulation of Ubiquitin­proteasome pathway is sig­ the HAUSP interaction domain, but not gene expression, telomere length, cell nificant in the stability of DNMT1[8], but the full­length protein. These results differentiation, X chromosome inactiva­ ubiquitin­mediated protein degradation show the coordination between ubiquit­ tion, genomic imprinting and tumori­ can be enhanced or attenuated by some ination of DNMT1 by UHRF1 and deu­ genesis[1]. DNA methylation patterns modifications like acetylation/deacety­ biquitination by HAUSP. Furthermore, are established de novo by DNA meth­ lation, protein methylation/demethyla­ they found that knockdown of HDAC1 yltransferases (DNMTs) 3a and 3b, tion, phosphorylation and S­nitrosy­ increased DNMT1 acetylation, and whereas DNMT1 maintains the parent­ lation[9–11]. Estève et al demonstrated reduced DNMT1 abundance. Addition­ specific methylation from parental cells that SET7­mediated lysine methy lation ally, acetyltransferase Tip60 which was to their progeny[2]. After DNA replica­ of DNMT1 decreased DNMT1 level found to acetylate DNMT1 promoted its tion, the new DNA strand is unmethy­ by ubiquitin­mediated degradation[10]. ubiquitination, then destabilized it. At lated. Thus with the mother methylated Furthermore, an early study[12] showed last, Tip60 and HAUSP were found to strand, the DNA is hemimethylated.
    [Show full text]
  • 1519038862M28translationand
    Paper No. : 15 Molecular Cell Biology Module : 28 Translation and Post-translation Modifications in Eukaryotes Development Team Principal Investigator : Prof. Neeta Sehgal Department of Zoology, University of Delhi Co-Principal Investigator : Prof. D.K. Singh Department of Zoology, University of Delhi Paper Coordinator : Prof. Kuldeep K. Sharma Department of Zoology, University of Jammu Content Writer : Dr. Renu Solanki, Deen Dayal Upadhyaya College Dr. Sudhida Gautam, Hansraj College, University of Delhi Mr. Kiran K. Salam, Hindu College, University of Delhi Content Reviewer : Prof. Rup Lal Department of Zoology, University of Delhi 1 Molecular Genetics ZOOLOGY Translation and Post-translation Modifications in Eukaryotes Description of Module Subject Name ZOOLOGY Paper Name Molecular Cell Biology; Zool 015 Module Name/Title Cell regulatory mechanisms Module Id M28: Translation and Post-translation Modifications in Eukaryotes Keywords Genome, Proteome diversity, post-translational modifications, glycosylation, phosphorylation, methylation Contents 1. Learning Objectives 2. Introduction 3. Purpose of post translational modifications 4. Post translational modifications 4.1. Phosphorylation, the addition of a phosphate group 4.2. Methylation, the addition of a methyl group 4.3. Glycosylation, the addition of sugar groups 4.4. Disulfide bonds, the formation of covalent bonds between 2 cysteine amino acids 4.5. Proteolysis/ Proteolytic Cleavage 4.6. Subunit binding to form a multisubunit protein 4.7. S-nitrosylation 4.8. Lipidation 4.9. Acetylation 4.10. Ubiquitylation 4.11. SUMOlytion 4.12. Vitamin C-Dependent Modifications 4.13. Vitamin K-Dependent Modifications 4.14. Selenoproteins 4.15. Myristoylation 5. Chaperones: Role in PTM and mechanism 6. Role of PTMs in diseases 7. Detecting and Quantifying Post-Translational Modifications 8.
    [Show full text]
  • Transcriptional Regulation by Histone Ubiquitination and Deubiquitination
    Downloaded from genesdev.cshlp.org on September 30, 2021 - Published by Cold Spring Harbor Laboratory Press PERSPECTIVE Transcriptional regulation by histone ubiquitination and deubiquitination Yi Zhang1 Department of Biochemistry and Biophysics, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, North Carolina 27599, USA Ubiquitin (Ub) is a 76-amino acid protein that is ubiqui- The fact that histone ubiquitination occurs in the largely tously distributed and highly conserved throughout eu- monoubiquitinated form and is not linked to degrada- karyotic organisms. Whereas the extreme C-terminal tion, in combination with the lack of information regard- four amino acids are in a random coil, its N-terminal 72 ing the responsible enzymes, prevented us from under- amino acids have a tightly folded globular structure (Vi- standing the functional significance of this modification. jay-Kumar et al. 1987; Fig. 1A). Since its discovery ∼28 Recent identification of the E2 and E3 proteins involved years ago (Goldknopf et al. 1975), a variety of cellular in H2B ubiquitination (Robzyk et al. 2000; Hwang et al. processes including protein degradation, stress response, 2003; Wood et al. 2003a) and the discovery of cross-talk cell-cycle regulation, protein trafficking, endocytosis sig- between histone methylation and ubiquitination (Dover naling, and transcriptional regulation have been linked et al. 2002; Sun and Allis 2002) have set the stage for to this molecule (Pickart 2001). Ubiquitylation is pro- functional analysis of histone ubiquitination. In a timely posed to serve as a signaling module, and the informa- paper published in the previous issue of Genes & Devel- tion transmitted by this tag may depend on the nature of opment, Shelley Berger and colleagues (Henry et al.
    [Show full text]
  • How Genes Work
    Help Me Understand Genetics How Genes Work Reprinted from MedlinePlus Genetics U.S. National Library of Medicine National Institutes of Health Department of Health & Human Services Table of Contents 1 What are proteins and what do they do? 1 2 How do genes direct the production of proteins? 5 3 Can genes be turned on and off in cells? 7 4 What is epigenetics? 8 5 How do cells divide? 10 6 How do genes control the growth and division of cells? 12 7 How do geneticists indicate the location of a gene? 16 Reprinted from MedlinePlus Genetics (https://medlineplus.gov/genetics/) i How Genes Work 1 What are proteins and what do they do? Proteins are large, complex molecules that play many critical roles in the body. They do most of the work in cells and are required for the structure, function, and regulation of thebody’s tissues and organs. Proteins are made up of hundreds or thousands of smaller units called amino acids, which are attached to one another in long chains. There are 20 different types of amino acids that can be combined to make a protein. The sequence of amino acids determineseach protein’s unique 3-dimensional structure and its specific function. Aminoacids are coded by combinations of three DNA building blocks (nucleotides), determined by the sequence of genes. Proteins can be described according to their large range of functions in the body, listed inalphabetical order: Antibody. Antibodies bind to specific foreign particles, such as viruses and bacteria, to help protect the body. Example: Immunoglobulin G (IgG) (Figure 1) Enzyme.
    [Show full text]
  • Histone Methylation by Temozolomide; a Classic DNA Methylating Anticancer Drug
    ANTICANCER RESEARCH 36: 3289-3300 (2016) Histone Methylation by Temozolomide; A Classic DNA Methylating Anticancer Drug TIELI WANG1, AMANDA J. PICKARD2 and JAMES M. GALLO2 1Department of Chemistry and Biochemistry, California State University Dominguez Hills, Carson, CA, U.S.A.; 2Department of Pharmacology and Systems Therapeutics, Icahn School of Medicine at Mount Sinai, New York, NY, U.S.A. Abstract. Background/Aim: The alkylating agent, adults (1). Despite advances in multimodal therapies of temozolomide (TMZ), is considered the standard-of-care for surgical extirpation, radiotherapy and chemotherapy, GBMs high-grade astrocytomas –known as glioblastoma multiforme remain a cancer of poor prognosis that can be attributed to (GBM)– an aggressive type of tumor with poor prognosis. The the aggressive nature of the tumors and the development of therapeutic benefit of TMZ is attributed to formation of DNA resistance to radiation and chemotherapy (2). Out of adducts involving the methylation of purine bases in DNA. We chemotherapeutic approaches to GBMs, temozolomide investigated the effects of TMZ on arginine and lysine amino (TMZ) is the main alkylating agent used, based on its ability acids, histone H3 peptides and histone H3 proteins. Materials to increase the median survival (3-6). and Methods: Chemical modification of amino acids, histone TMZ possesses favorable pharmacokinetic characteristics H3 peptide and protein by TMZ was performed in phosphate with high oral bioavailability and blood-brain barrier (BBB) buffer at physiological pH.
    [Show full text]
  • DNA Methylation Models Histone Acetylation
    scientific correspondence the unmethylated tk gene (also 4.5-fold). In mediator of the global repression associated contrast, methylated tk sequences behave with DNA methylation. DNA methylation models like endogenous inactive genes (for exam- It has been shown that the presence of ple, the Igk gene), and are not preferentially methyl groups on exogenously introduced histone acetylation associated with acetylated histones (Fig. sequences makes local chromatin structure 1a). Because identical DNA sequences were less accessible to the transcription machin- One of the main determinants of chromatin used in both transfection experiments, this ery7 and molecular probes, such as DNaseI 8. structure is histone acetylation1. Local chro- decreased level of chromatin acetylation To determine whether this inactive chro- mosomal acetylation can be regulated must be due to the presence of 5-methyl matin structure is brought about by histone dynamically, both through the involvement cytosine. These experiments therefore deacetylation, cells carrying fully methyl-8 of transactivating factors with intrinsic his- demonstrate that DNA methylation influ- ated copies of the HSV tk gene were treated tone acetylase activity, and through the ences local histone acetylation, and it has with TSA. Although remaining fully methyl- recruitment of deacetylase complexes that now been shown that the methyl-binding ated (data not shown), these sequences are repress gene expression2. Histone acetyla- protein MeCP2 is probably involved in this converted to a DNaseI-sensitive conforma- tion status is transiently modified from one process by recruiting histone deacetylases3,4. tion (Fig. 1c), indicating that histone state to another in response to physiological We investigated whether this under- deacetylation itself is a critical factor in the changes operating in the cell.
    [Show full text]
  • Basic Molecular Genetics for Epidemiologists F Calafell, N Malats
    398 GLOSSARY Basic molecular genetics for epidemiologists F Calafell, N Malats ............................................................................................................................. J Epidemiol Community Health 2003;57:398–400 This is the first of a series of three glossaries on CHROMOSOME molecular genetics. This article focuses on basic Linear or (in bacteria and organelles) circular DNA molecule that constitutes the basic physical molecular terms. block of heredity. Chromosomes in diploid organ- .......................................................................... isms such as humans come in pairs; each member of a pair is inherited from one of the parents. general increase in the number of epide- Humans carry 23 pairs of chromosomes (22 pairs miological research articles that apply basic of autosomes and two sex chromosomes); chromo- science methods in their studies, resulting somes are distinguished by their length (from 48 A to 257 million base pairs) and by their banding in what is known as both molecular and genetic epidemiology, is evident. Actually, genetics has pattern when stained with appropriate methods. come into the epidemiological scene with plenty Homologous chromosome of new sophisticated concepts and methodologi- cal issues. Each of the chromosomes in a pair with respect to This fact led the editors of the journal to offer the other. Homologous chromosomes carry the you a glossary of terms commonly used in papers same set of genes, and recombine with each other applying genetic methods to health problems to during meiosis. facilitate your “walking” around the journal Sex chromosome issues and enjoying the articles while learning. Sex determining chromosome. In humans, as in Obviously, the topics are so extensive and inno- all other mammals, embryos carrying XX sex vative that a single short glossary would not be chromosomes develop as females, whereas XY sufficient to provide you with the minimum embryos develop as males.
    [Show full text]
  • The Key Role of DNA Methylation and Histone Acetylation in Epigenetics of Atherosclerosis
    J Lipid Atheroscler. 2020 Sep;9(3):419-434 Journal of https://doi.org/10.12997/jla.2020.9.3.419 Lipid and pISSN 2287-2892·eISSN 2288-2561 Atherosclerosis Review The Key Role of DNA Methylation and Histone Acetylation in Epigenetics of Atherosclerosis Han-Teo Lee ,1,2,* Sanghyeon Oh ,1,2,* Du Hyun Ro ,1,2,3,* Hyerin Yoo ,1,2 Yoo-Wook Kwon 4,5 1Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science, Seoul National University, Seoul, Korea 2Interdisciplinary Program in Stem Cell Biology, Graduate School of Medicine, Seoul National University, Seoul, Korea 3Department of Orthopedic Surgery, Seoul National University Hospital, Seoul, Korea 4Strategic Center of Cell and Bio Therapy for Heart, Diabetes & Cancer, Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea Received: May 8, 2020 5Department of Medicine, College of Medicine, Seoul National University, Seoul, Korea Revised: Sep 14, 2020 Accepted: Sep 15, 2020 Correspondence to ABSTRACT Yoo-Wook Kwon Biomedical Research Institute, Seoul National Atherosclerosis, which is the most common chronic disease of the coronary artery, constitutes University Hospital, 103 Daehak-ro, Jongno- a vascular pathology induced by inflammation and plaque accumulation within arterial vessel gu, Seoul 03080, Korea. E-mail: [email protected] walls. Both DNA methylation and histone modifications are epigenetic changes relevant for atherosclerosis. Recent studies have shown that the DNA methylation and histone *Han-Teo Lee, Sanghyeon Oh and Du Hyun Ro modification systems are closely interrelated and mechanically dependent on each other. contributed equally to this work. Herein, we explore the functional linkage between these systems, with a particular emphasis Copyright © 2020 The Korean Society of Lipid on several recent findings suggesting that histone acetylation can help in targeting DNA and Atherosclerosis.
    [Show full text]
  • Detecting DNA Base Modifications Using SMRT Sequencing
    White Paper Base Modifications Detecting DNA Base Modifications Using Single Molecule, Real-Time Sequencing Introduction Types of Base Modification in Biology Base modifications are important to the DNA base modifications have a variety of functional understanding of biological processes such as gene roles which include: expression, host-pathogen interactions, DNA damage, and DNA repair1. Single Molecule, Real- • Epigenetic markers for influencing gene Time (SMRT®) sequencing has the potential to expression such as 5-mC, 5-hmC, 5- revolutionize the study of base modifications through formylcytosine (5-fC), and 5-carboxylcytosine (5- direct detection of unamplified source material. caC). • Bacterial identity markers for affecting host- Traditionally, it has been a challenge to study the pathogen interactions such as 6-mA, 4-mC, and wide variety of base modifications that are seen in 5-mC. nature. Most high-throughput techniques focus only on cytosine methylation and involve both bisulfite • Bacterial epigenetic markers for regulating DNA sequencing to convert unmethylated cytosine replication and repair and transcription nucleotides to uracil nucleotides, and comparison of regulation such as 6-mA. sequence reads from bisulfite-treated and untreated 2 • Products of DNA damage such as 8-oxoguanine samples . SMRT sequencing, in contrast, does not (8-oxoG) and 8-oxoadenine (8-oxoA). require base conversion within the source material in order to detect base modifications. Instead, the NH NH NH H NH H kinetics of base addition is measured during the 2 2 2 2 O CH3 N N OH N O N O normal course of sequencing. These kinetic measurements present characteristic patterns in O N O N O N O N response to a wide variety of base modifications – 5-mC 5-hmC 5-fC 5-caC researchers at PacBio have been able to observe CH unique kinetic characteristics for over 25 base 3 CH3 HN HN O 3 NH2 modifications .
    [Show full text]